Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-113591

See remarks sold 6,200 shares at an average $48.13 ($298,437)

  • See remarks acquired 6,200 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Goldshleger Ilya See remarks 2024-10-04 Option exercise 10b5-1 +3,100 $15.08 $46,748 45,346 D: show line 1 in the form
Goldshleger Ilya See remarks 2024-10-04 Sale 10b5-1 −2,866 $47.96 $137,445 42,480 D: show line 2 in the form
Goldshleger Ilya See remarks 2024-10-04 Sale 10b5-1 −28 $48.47 $1,357 42,452 D: show line 3 in the form
Goldshleger Ilya See remarks 2024-10-04 Sale 10b5-1 −206 $48.65 $10,022 42,246 D: show line 4 in the form
Goldshleger Ilya See remarks 2024-10-08 Option exercise 10b5-1 +3,100 $15.08 $46,748 45,346 D: show line 5 in the form
Goldshleger Ilya See remarks 2024-10-08 Sale 10b5-1 −3,100 $48.26 $149,612 42,246 D: show line 6 in the form
Open-market sales · 6,200 sh · avg $48.13 · $298,437

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Goldshleger Ilya See remarks 2024-10-04 Option exercise · Stock Option (right to buy) 10b5-1 −3,100 96,602 D: show line 7 in the form
Goldshleger Ilya See remarks 2024-10-08 Option exercise · Stock Option (right to buy) 10b5-1 −3,100 93,502 D: show line 8 in the form
Loading xslF345X05/ownership.xml…